Advertisements

Augmentin Duo Forte

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Augmentin Duo Forte

Quick Facts

Property Description
Active Ingredients Amoxicillin, Clavulanic acid
Form Film-coated tablet, Powder for oral suspension
Pharmacological Class Broad-spectrum antibiotic (Penicillin-class)
Common Use Management of bacterial infections
Origin Semi-synthetic combination

Identity and Pharmaceutical Classification

Augmentin Duo Forte is formally classified as a broad-spectrum antibiotic that belongs to the penicillin-class antibacterial agent group. The medicine is commonly known by its International Nonproprietary Name (Co-amoxiclav), which designates it as a fixed-dose combination product designed for systemic treatment. This formulation is clinically recognized for its reliable efficacy in managing infections where resistance is a concern. The drug is administered via the oral route, being primarily available as a film-coated tablet or a powder for oral suspension, allowing flexibility for different patient groups.


Composition: The Amoxicillin and Clavulanic Acid Duo

The preparation contains two distinct active ingredients: the antibiotic Amoxicillin and Clavulanic acid (supplied as Potassium Clavulanate). Amoxicillin's main role is its bactericidal action, functioning by disrupting bacterial cell wall synthesis. The differentiating factor for this formulation is Clavulanic acid, which serves not as an antibiotic, but as a synergistic beta-lactamase inhibitor. This means the combination is effective against bacterial strains that produce specific defensive enzymes that would otherwise inactivate Amoxicillin.


General Purpose of the Potentiated Formulation

The primary general purpose of this formulation is to act as a potentiated antimicrobial capable of achieving resistance circumvention. This strategic combination prevents the enzymatic destruction of the Amoxicillin component, allowing the antibiotic to retain its full therapeutic potential against otherwise resistant microbes and providing an option for the management of bacterial infection.

Regulatory References

  1. Amoxicillin and Clavulanic Acid: MedlinePlus Drug Information
Advertisements

What side effects are possible with Augmentin Duo Forte?

Possible side effects and safety information

Official regulatory documents classify the adverse reactions of this combination medicine based on frequency and affected body system. These classifications are intended to communicate the medicine’s official safety profile in a neutral, medically grounded manner.

Adverse Reaction Frequencies and Systems

The most frequently documented adverse event is Diarrhoea, which is classified as Very Common (occurring in ge 1/10 patients). Reactions categorized as Common (in ge 1/100 to < 1/10) include Nausea, Vomiting, and Mucocutaneous candidosis (thrush). The spectrum of side effects primarily involves the Gastrointestinal disorders and Skin and subcutaneous tissue disorders, as outlined in the official System-Organ Classes.

Serious Adverse Reactions and Safety Constraints

The regulatory profile highlights rare but clinically significant reactions, including severe Hypersensitivity Reactions such as Anaphylaxis and Angioedema, as well as severe Hepato-biliary disorders (Hepatitis and Cholestatic jaundice). Severe cutaneous adverse reactions, such as Stevens-Johnson syndrome, are also officially documented.

Use of this medicine is subject to defined contraindications. It must not be used in patients with a confirmed history of hypersensitivity to any penicillin or in individuals with a history of jaundice or hepatic dysfunction previously associated with Amoxicillin/Clavulanate use. Hepatic events have been reported more frequently in older adults and appear to be associated with prolonged treatment.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented overdose information for Augmentin Duo Forte (Amoxicillin/Clavulanate Potassium), strictly based on government regulatory sources.

Documented Manifestations and Risks

Element Official Regulatory Statement
Documented Manifestations Symptoms may include gastrointestinal distress (abdominal pain, vomiting, diarrhea) and neurological effects such as hyperactivity or drowsiness. The occurrence of convulsions is specifically associated with high dosage or impaired renal function.
Severe Outcomes The potential for amoxicillin crystalluria is a documented risk, which in severe cases has been reported to cause renal failure or oliguric renal failure secondary to interstitial nephritis. Renal impairment is generally considered reversible upon cessation of the drug.
Population-Specific Note Patients with impaired renal function are at a higher risk of elevated drug concentrations, increasing the likelihood of neurological effects like convulsions.

Required Emergency Actions

Immediate medical attention is required in cases of suspected severe overdosage or if serious symptoms develop. The medication must be discontinued promptly upon suspicion of an overdose. Official management procedures focus on supportive care:

  • Supportive Treatment: Treatment is symptomatic, and supportive measures are instituted as required.
  • Fluid Management: Maintaining adequate fluid intake and urinary output is advised to reduce the possibility of amoxicillin crystalluria.
  • Drug Removal: Hemodialysis is documented as a procedure that can effectively remove both the Amoxicillin and Clavulanate components from the circulation.
Advertisements

Therapeutic Uses of Augmentin Duo Forte

Uses and Therapeutic Applications

Augmentin Duo Forte is prescribed to treat a range of infections that are confirmed or strongly suspected to be caused by susceptible bacteria, including those that produce certain resistance mechanisms. The dual-component formulation helps ensure the efficacy of the treatment against a broader spectrum of bacteria.

The main therapeutic applications for this medication include the management of:

  • Lower Respiratory Tract Infections: Such as pneumonia or acute exacerbations of chronic bronchitis.
  • Upper Respiratory Tract Infections: Specifically, acute bacterial sinusitis and acute otitis media (ear infection).
  • Skin and Skin Structure Infections
  • Urinary Tract Infections (UTIs)

The benefit of this combination drug is its ability to overcome common bacterial resistance, making it an appropriate choice when standard penicillin-class treatments may be ineffective. This helps facilitate the resolution of bacterial illness when used as directed by a healthcare professional.


Quick Facts: Therapeutic Domain

  • Treats bacterial lower respiratory tract illness.
  • Indicated for acute bacterial sinusitis and otitis media.
  • Used for certain skin and urinary tract bacterial infections.
  • Effective against specific bacteria that exhibit resistance.
Advertisements

Eligibility and Restrictions for Use

Official Eligibility Profile

Regulatory authorities define the specific patient populations who are eligible to use Augmentin Duo Forte and those who are strictly prohibited from using it. Eligibility is determined by age, pre-existing conditions, and hypersensitivity history.

Classification Eligibility Rule
Contraindicated Populations Individuals with a prior history of a severe allergic reaction (e.g., anaphylaxis) to penicillins or other beta-lactam antibiotics (like cephalosporins) must not use this medicine.
Prior Hepatic Injury Contraindicated for patients with a history of cholestatic jaundice or other severe liver dysfunction specifically associated with a previous use of Amoxicillin/Clavulanate potassium.

Condition-Based and Age Restrictions

  • Age-Related Eligibility: The medicine is approved for adults and pediatric patients starting from 3 months of age and older. Children weighing 40 kg or more are dosed according to adult recommendations.
  • Kidney Impairment: The tablet formulation is not recommended for patients with severe renal impairment (creatinine clearance leq 30 mL/min). Dosing requires adjustment and closer monitoring for all other degrees of kidney impairment.
  • Liver Impairment: Use requires caution and regular monitoring of liver function in patients with evidence of hepatic dysfunction.
  • Infectious Mononucleosis: The medication should be avoided in patients with Mononucleosis (Glandular Fever) due to a high risk of developing a skin rash.
  • Pregnancy and Lactation: Use during pregnancy is generally permitted only if clearly needed; components pass into breast milk, requiring medical consultation to weigh potential effects on the infant.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Augmentin Duo Forte (Amoxicillin/Clavulanate) is officially documented based on pharmacokinetic and pharmacodynamic patterns, as outlined by regulatory authorities.

Renal Transport Inhibitors

Co-administration with Probenecid is not recommended. Probenecid decreases the renal tubular secretion of the Amoxicillin component, resulting in increased and prolonged plasma concentrations of Amoxicillin. Similarly, the co-administration may increase the serum concentrations of Methotrexate due to competition for a common renal elimination pathway, which requires caution.

Pharmacodynamic and Exposure-Modifying Interactions

  • Oral Anticoagulants: The use of the product with oral anticoagulants, such as Warfarin, may prolong the prothrombin time (INR). This necessitates careful monitoring of clotting parameters.
  • Allopurinol: Concurrent use with Allopurinol is documented to increase the incidence of skin rash.
  • Hormonal Contraceptives: Combined oral contraceptives may have their effectiveness reduced due to an interaction linked to the alteration of intestinal flora.

Population and Procedural Notes

Patients with hepatic impairment require regular monitoring of liver function. Additionally, the presence of high Amoxicillin concentrations can cause false-positive results when testing urine glucose using specific copper-reduction methods.

Advertisements

Mechanism of Action

The action of Augmentin Duo Forte is based on a precise pharmacodynamic synergy between its two active ingredients, resulting in the destruction of susceptible bacteria by collapsing their structural integrity.

Inhibition of Bacterial Cell Wall Assembly

The antibiotic Amoxicillin works by targeting Penicillin-Binding Proteins (PBPs), which are enzymes critical for synthesizing the protective bacterial cell wall. By binding to and inactivating these PBPs, Amoxicillin inhibits the final transpeptidation step of the cell wall's assembly pathway. This structural failure is the causal factor that triggers the lysis (rupture) of the bacterial cell due to internal osmotic pressure.

Inactivation of Microbial Resistance Enzymes

The second component, Clavulanic acid, acts as a mechanism-based inhibitor of beta-lactamase enzymes. These enzymes are a common bacterial defense that hydrolyzes Amoxicillin's active structure. By irreversibly neutralizing these beta-lactamases, Clavulanic acid protects the Amoxicillin molecule, allowing it to remain intact and capable of engaging the PBPs. This synergy allows for the continuation of the bactericidal mechanism against strains that are resistant due to beta-lactamase production.

Advertisements

Dosage and Administration Information

Official Administration and Dosing Guidelines

Augmentin Duo Forte (amoxicillin/clavulanate potassium) must be used strictly according to the regimen defined in established prescribing guidelines. The medication is available as an oral film-coated tablet or a powder for oral suspension. Treatment may be initiated parenterally before transitioning to an oral preparation.

Key Administration Instructions:

Instruction Detail
Timing in Relation to Meals Take the dose at the start of a meal to enhance the absorption of clavulanate potassium and minimize potential gastrointestinal intolerance.
Standard Adult Dosing The high-dose tablet (e.g., 875 mg/125 mg) is typically administered twice daily (every 12 hours). Lower strengths may require administration three times daily (every 8 hours).
Course Duration The duration of treatment is commonly 7 to 10 days. Treatment must not be extended beyond 14 days without a medical review.
Tablets and Interchanges Tablets may be broken at a score line for ease of swallowing, but they should not be chewed. Formulations with different amoxicillin:clavulanate ratios are not substitutable for one another.

Population-Specific Dosing Rules:

  • Renal Impairment: Dose adjustments are mandatory for patients with reduced kidney function (creatinine clearance < 30 mL/min). The 875 mg/125 mg formulation is not recommended in these patients.
  • Missed Dose: If a dose is missed, take it as soon as remembered, but if it is almost time for the next dose (within 6 hours for a twice-daily regimen), skip the missed dose and resume the regular schedule. Do not take a double dose.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Studies Evaluating Use and Mechanism

Research has explored the use of Augmentin Duo Forte (amoxicillin/clavulanate) in treating bacterial infections, focusing on its administration as part of a combination therapy. The body of evidence reviewed by researchers suggests it remains limited regarding large-scale, long-term studies yet published.

One study evaluated whether the combination was associated with a change in symptom severity over a defined timeframe in community-acquired pneumonia. This trial also reported an observed difference in symptom progression compared with placebo.


Pharmacological Activity Research

Studies examined whether a change in inflammation markers was observed; co-administration with food was explored. Other research suggests that the drug is proposed to involve activity related to the cyclooxygenase-2 (COX-2) enzyme.

The relationship between this mechanism and its therapeutic use was assessed. The clavulanate component functions as a beta-lactamase inhibitor, preventing certain bacterial enzymes from inactivating the amoxicillin, thereby expanding the combination's spectrum of bacterial coverage.


Safety and Drug-Interaction Findings

Grapefruit avoidance was part of the study protocol, as researchers explored its potential impact on therapeutic response.

Early studies examined the tolerability profile in most individuals; investigators reported specific observations regarding individuals with kidney disease. The most commonly reported adverse events in the trials included mild gastrointestinal distress and transient dizziness. It is not yet clear whether long-term use affects liver function; however, hepatic dysfunction, including hepatitis, has been associated with its use, particularly in older adults and prolonged use, though it is usually reversible.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Augmentin Duo Forte (FAQ)


Q: What is Augmentin Duo Forte actually used for, besides common infections?

A: According to official regulatory documents, this medication is approved for a variety of infections where susceptible bacteria are involved. Approved uses commonly include infections of the ear, nose, throat, skin, soft tissues, respiratory tract (like pneumonia), and the urinary tract. Its use is generally reserved for treating infections that are proven or strongly suspected to be bacterial.


Q: Is Augmentin Duo Forte considered a strong antibiotic?

A: The drug is officially described as a potentiated antimicrobial. This means it contains the antibiotic amoxicillin combined with clavulanic acid. The clavulanic acid component helps to protect the amoxicillin from inactivation by certain beta-lactamase enzymes, thereby supporting its activity against specific resistant strains.


Q: What is the difference between Augmentin Duo Forte and standard Amoxicillin?

A: Augmentin Duo Forte is a combination product containing two active ingredients: the antibiotic amoxicillin and clavulanic acid. Standard amoxicillin contains only the antibiotic. The inclusion of clavulanic acid distinguishes this formulation, as it helps counteract a common defense mechanism used by certain resistant bacteria.


Q: Can Augmentin Duo Forte cause a yeast infection?

A: Yes, official safety information lists mucocutaneous candidosis as a Common side effect. This is the medical term for a yeast infection, which can affect the mouth or vagina. This is a documented reaction to the medication, and individuals may wish to discuss this possibility with a healthcare provider.


Q: Is Augmentin Duo Forte safe for older adults?

A: The medication is approved for use in older adults. However, official warnings state that adverse events affecting the liver (hepatic events) have been reported more frequently in this patient group. Because the drug is primarily eliminated by the kidneys, patients with reduced kidney function may require specific management.


Q: Is this antibiotic appropriate for children?

A: Yes, regulatory authorities have approved this medication for use in pediatric patients. The official indications allow its use in children starting from three months of age and older. Dosage management for younger children is based on individual factors like body weight.


Q: Is there a risk of liver issues with Augmentin Duo Forte?

A: Yes, official warnings describe a risk of severe hepatic dysfunction, including hepatitis and cholestatic jaundice. These events have been associated with its use, particularly with prolonged treatment. These events have generally been reported to be reversible upon discontinuation of the medication.


Q: Can Augmentin Duo Forte affect the results of blood tests?

A: Official labeling mentions that high levels of amoxicillin in the body can cause false positive results in specific urine glucose tests that use copper-reduction methods. It is important that healthcare providers are aware of this medication when laboratory tests are ordered.


Q: What are the documented long-term effects of taking this drug?

A: Official prescribing rules usually limit the duration of treatment to a maximum of 14 days without medical reassessment. While there are no specific claims about long-term effects, the official duration is limited because hepatic events have been associated with prolonged treatment.


Q: Can you be allergic to Augmentin Duo Forte if you've never had a reaction before?

A: As with any penicillin-class antibiotic, a first-time allergic reaction remains a possibility even if an individual has no prior history of an allergy. It is officially contraindicated for individuals with a documented history of allergy to penicillins or other beta-lactam antibiotics.


Q: Why is the 'Duo Forte' formulation different from other versions?

A: The term 'Forte' is used to designate a formulation that has a higher dosage strength of the active ingredients compared to standard versions. The different Augmentin formulations are not always interchangeable, as they contain varying ratios of amoxicillin to clavulanic acid.


Q: Is Augmentin Duo Forte safe to take during pregnancy or while breastfeeding?

A: Regulatory information states that use during pregnancy is permitted only if clearly needed, following a thorough assessment by a healthcare professional. Both amoxicillin and clavulanic acid pass into breast milk, which requires medical consideration for the potential effects on a nursing infant.


Q: Why do official guidelines emphasize completing the full course of treatment?

A: Official guidelines underscore the importance of completing the full prescribed course of therapy. This practice helps ensure the elimination of susceptible bacteria and supports efforts to limit the potential for the development of antibiotic resistance.


Q: What are some common drug interactions to be aware of?

A: Officially documented interactions include those with oral anticoagulants (medications to prevent clotting) and allopurinol (used to treat gout). Using this antibiotic with probenecid is also noted, as it increases the concentration of amoxicillin in the body.


Q: Is it true that Augmentin Duo Forte is often prescribed when other antibiotics fail?

A: The drug is classified as a potentiated antimicrobial because it is designed to overcome a common mechanism of bacterial resistance, namely the production of beta-lactamase enzymes. Its expanded spectrum of activity is relevant for addressing certain strains that may exhibit resistance to other standard antibiotics.


Q: Does taking Augmentin Duo Forte affect future antibiotic use?

A: The use of any antibiotic, including Augmentin Duo Forte, contributes to the overall pattern of microbial resistance. Excessive or unnecessary use can affect the effectiveness of this and other antibiotics for treating future infections in that individual or community.


Q: What is the meaning of the 'Forte' dosage strength?

A: The term 'Forte' is used within the official product documentation to indicate a formulation that provides a higher dosage of the active ingredients. This distinguishes it from non-Forte versions of the medication.


Q: How long does Augmentin Duo Forte stay in your system?

A: Based on pharmacokinetic data from regulatory sources, the elimination half-life for both amoxicillin and clavulanic acid is approximately one hour. This indicates that both components are largely cleared from the body, primarily by the kidneys, within a few hours.


Q: Is it common to feel tired while taking Augmentin Duo Forte?

A: While tiredness is not directly listed, official documents report Central Nervous System effects. These include uncommon dizziness and very rare effects like hyperactivity, anxiety, and confusion.


Q: Does Augmentin Duo Forte work for viral infections?

A: Official indications clearly state that this medication is an antibiotic and is effective only against infections caused by susceptible bacteria. It is not indicated for treating viral infections like the common cold or flu.


Q: What kind of bacteria does Augmentin Duo Forte target?

A: Official product information indicates that the combination is active against a broad spectrum of medically important bacteria. This includes certain Gram-positive and Gram-negative bacteria, especially those resistant strains that produce beta-lactamase enzymes.


Q: What are the signs of an allergic reaction to Augmentin Duo Forte?

A: As with all penicillin-class drugs, severe allergic reactions (hypersensitivity) are a risk. Symptoms officially described include hives or rash, difficulty breathing, and swelling of the face, tongue, or throat.


Q: Can Augmentin Duo Forte cause changes in mood or anxiety?

A: Yes, official side effect listings include several central nervous system effects. Specifically, rare side effects documented in official sources include anxiety, insomnia, and very rare reports of reversible hyperactivity and agitation.


Q: Are there any common foods or drinks that interact with Augmentin Duo Forte?

A: Regulatory information advises taking the medication at the start of a meal to help maximize absorption and reduce the possibility of digestive discomfort. No specific common food or drink is listed as causing an interaction that must be avoided.


Q: Does Augmentin Duo Forte lose effectiveness over time if overused?

A: The widespread and excessive use of any antibiotic is a contributing factor to the development of microbial resistance. This resistance can cause the drug to become less effective against the same bacteria for a person or within the community over time.


Q: Does the medicine contain gluten or lactose?

A: Official excipient lists detail all components used in the formulation. For example, the tablet forms typically contain lactose. Patients concerned about specific allergens like gluten should consult the excipient list provided in the official product information for their specific formulation.


Q: Does this antibiotic interact with diabetes medications?

A: Regulatory sources warn that high concentrations of amoxicillin in the body can cause false-positive results when using specific copper-reduction urine glucose tests. Patients managing diabetes should be aware of this potential interference with their monitoring.


Q: Are there common misunderstandings about what Augmentin Duo Forte treats?

A: Regulatory documents explicitly clarify that this drug is only indicated for bacterial infections. A key message from official bodies is the importance of reserving this drug's use for when a bacterial infection is confirmed or strongly suspected, not for general illness.


Q: What is the key difference between how Augmentin Duo Forte works and how penicillin works?

A: The mechanism of action is two-fold: the amoxicillin component acts like penicillin by stopping the bacteria from building their cell walls. The added clavulanic acid is a beta-lactamase inhibitor that defends the amoxicillin from the bacteria's resistance enzymes.


Q: Are there generic versions of Augmentin Duo Forte?

A: Yes, official national drug listings and registries confirm that multiple generic formulations containing the same active ingredients, Amoxicillin and Clavulanate Potassium, are available commercially.


Q: Why is Augmentin Duo Forte commonly used for respiratory tract infections?

A: Official indications include its approval for treating various bacterial infections of the lower respiratory tract, such as pneumonia, and acute bacterial sinusitis. This broad spectrum of officially approved uses makes it a common prescription for these types of infections.


Q: Can I take Augmentin Duo Forte if I have a history of colitis?

A: Official warnings caution about the possibility of developing antibiotic-associated colitis, which can occur with most antibiotics. Regulatory sources advise that patients with a history of gastrointestinal disease should use the drug with caution and be monitored by a healthcare professional.

Advertisements

How should Augmentin Duo Forte be stored and disposed of?

Official Storage Requirements

Augmentin Duo Forte film-coated tablets must be stored according to regulatory requirements to preserve the stability of the Amoxicillin and Clavulanic acid combination. The medicine must be stored at room temperature, which means the temperature must not exceed 25°C (77°F). The tablets must be actively protected from moisture, heat, and direct light.

Packaging and Child Safety

To ensure this protection, the medicine must remain in its original container or package and be kept tightly closed. The official labeling requires that all medication be stored strictly out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Expired or unused Augmentin Duo Forte must be disposed of in accordance with local regulations. Patients are instructed to not throw away the medicine via household trash or wastewater. The official preferred method is to return unwanted medicine to any pharmacy for proper and safe pharmaceutical waste disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Augmentin Duo Forte found in:

A-Z Index: